Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-naive nonvalvular atrial fibrillation
BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Non-Valvular Atrial Fibrillation
J Brown, AR Shewale, J Talbert - Value in Health, 2016 - valueinhealthjournal.com
Objectives Few studies have assessed adherence to NOACs, especially using
contemporary data now that multiple NOACs are available. Methods Incident, treatment …
contemporary data now that multiple NOACs are available. Methods Incident, treatment …
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
JD Brown, AR Shewale… - Journal of managed …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
[HTML][HTML] Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
JD Brown, AR Shewale, JC Talbert - Journal of Managed Care & …, 2016 - ncbi.nlm.nih.gov
BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.
JD Brown, AR Shewale, JC Talbert - Journal of Managed Care & …, 2016 - europepmc.org
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
[引用][C] Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Non-Valvular Atrial Fibrillation
J Brown, AR Shewale, J Talbert - Value in Health, 2016 - infona.pl
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident,
Treatment-Naïve Non-Valvular Atrial Fibrillation × Close The Infona portal uses cookies, ie …
Treatment-Naïve Non-Valvular Atrial Fibrillation × Close The Infona portal uses cookies, ie …
[PDF][PDF] Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
JD Brown, AR Shewale, JC Talbert - 2016 - researchgate.net
ABSTRACT BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are
widely used for prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF) …
widely used for prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF) …
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
JD Brown, AR Shewale, JC Talbert - 2016 - hero.epa.gov
Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for prevention of
stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of NOACs is partially …
stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of NOACs is partially …
[PDF][PDF] Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
JD Brown, AR Shewale, JC Talbert - 2016 - researchgate.net
ABSTRACT BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are
widely used for prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF) …
widely used for prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF) …
[HTML][HTML] Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
JD Brown, AR Shewale, JC Talbert - Journal of managed care & …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …